L eft main (LM) coronary artery stenoses have conventionally been precluded from percutaneous coronary angioplasty because of the prohibitive risk of irreversible hemodynamic collapse after acute closure of the artery, and a relatively high risk of late sudden death. l When protected by left anterior descending and circumflex coronary artery bypass grafts, angioplasty of the LM coronary artery can be safely performed but is limited by a rate of recurrent stenosis in excess of 50%.* Coronary atherectomy has recently been advocated as an alternative procedure because of preliminary data suggesting a lower incidence of acute closure and restenosis after peripheral atherectomy. 3 A percutaneous cardiopulmonary support system has also been reported to reduce the hazards of high risk conventional angioplasty including angioplasty of the LM coronary artery. 4 We report the successful combined use of percutaneous cardiopulmonary bypass and LM coronary atherectomy in a patient incompletely protected by aortocoronary bypass grafts. Figure 1 ). Although it would be incompletely protected by coronary bypass grafts, coronary atherectomy was the procedure preferred because of the early recurrent stenosis after balloon angioplasty and the patient's desire to avoid a second surgical procedure.
To provide optimal hemoa'ynamic support during the procedure, cardiopulmonary bypass was initially instituted using the Bard cardiopulmonary support device. Right femoral arterial (20 Fr) and venous (22 i 14 THE AMERICAN JOURNAL OF CARDIOLOGY VOLUME 64 Fr) cannulas were inserted percutatime was monitored throughout the pass of the device. These electrocarneously under local anesthetic.
procedure. Atherectomy of the distal diographic changes were not associCommencement of bypass resulted LM stenosis was then performed ated with chest pain or hypotension in transient systemic hypotension, through an 11 Fr left coronary guidand resolved rapidly after removal which was readily corrected by the ing catheter advanced from the left of the catheter. After minimal residadministration of additional fluids femoral artery. A 7 Fr Simpson diual stenosis was demonstrated (Figthrough the support system. There-rectional atherectomy device ( Figure  ure 3 ), the atherectomy catheter was after, systemic systolic pressure re-2) was used to remove 12 cores of removed, the tissue obtained sent for mained between 85 and 110 mm Hg tissue. Placement of the device re-histologic examination and the supwith bypass flow rates of 3.5 to 4.5 sulted in 2 mm of ST-segment eleva-port system access site surgically literslmin. A total of 30,000 U of tion in monitored leads II and V's closed. The postoperative course was heparin was administered intravecommencing soon after left main oc-uneventful apart from the need for a nously and partial thromboplastin clusion and lasting throughout each 9-unit blood transfusion due to flGURE 2. Right anterior ablique proSaction shows the aWredomy device posit&d within the left main coromuy artery. losses within the support system and perioperative access site hemorrhage. A predischarge exercise thallium study showed a smallfixed apical defect but no reversible ischemia. The patient was discharged 7 days postoperatively receiving coumadin and diltiazem and has remained asymptomatic with no evidence of provocable ischemia during the 5-month follow-up period.
Technological advances in dilatation catheter and guidewire design have greatly facilitated complex coronary angioplasty. Unprotected balloon angioplasty of the LM coronary artery, however, has remained relatively contraindicated because of the risk of acute closure and cardiogenic shock and the inability to perform prolonged balloon inflations. Several alternatives5 are being evaluated to reduce the severity of myocardial ischemia during LM coronary interventions and may reduce the likelihood of restenosis. During conventional balloon angioplasty, myocardial ischemia may be minimized directly using an autoperfusion balloon catheter or by infusing fluorinated hydrocarbons into the distal coronary circulation through the central lumen of the dilatation catheter. Alternatively, the use of coronary sinus retroperfusion techniques, percutaneous cardiopulmonary support or intraaortic balloon counterpulsation may indirectly reduce myocardial ischemia. Although these strategies may permit prolonged balloon inflations, this has not yet been shown to reduce the incidence of intimal dissection or restenosis.
Two promising alternatives are being investigated. Coronary atherectomy, fust reported by Simpson et a1,6 has been successfully used in the LM coronary artery and preliminary data from peripheral vascular procedures suggest that the recurrence rate may be significantly reduced after this procedure. Adequate longterm follow-up studies, however, have not yet been completed. Second, a variety of endoluminal stents have been developed but, to date, these have not been deployed in the LM coronary artery. In this patient, the Coronary Artery Thermal Damage During Percutaneous **Hot Tip" Laser-Assisted Angioplasty Eric Rosenthal, MB, ChB, MRCP, Joseph K. Montarello, MB, BS, FRACP, Tim Palmer, MB, BS, MRCPathol, and Paul V.L. Curry, MD A major postulated advantage of laser angioplasty as an alternative treatment for occlusive vascular disease is its ability to vaporize obstructive atheroma.lJ The bare fiber systems used initially in the peripheral vasculature were able to traverse occlusions but the channels produced were small, subsequent balloon dilatation was always necessary and a high perforation rate was noted.3 The "hot tip" laser thermal probe produced by encasing the bare fiber tip in a metal cap4 overcame some of these limitations. The relatively large, smooth and oval metal cap enhanced coaxial placement while localization of all the laser energy (by heat conversion) at the tip made perforations infrequent.sy6 In the periphery this device recanalized lesions previously impassable to a guidewire and balloon system.7 For intracoronary use the smaller peripheral artery probes (1.5 to 1.7 mm tips) were modified to include an eccentric guidewire channel through the tip to facilitate coaxial advancement and subsequent balloon exchange. Percutaneous use of this probe in coronary artery disease has produced mixed results.8-'0 In this report we present experience using a more flexible laser thermal device. combined use of 2 of these emerging strategies allowed thorough removal of atheromatous plaque in the LM coronary artery. Although experience with each device is limited and long-term follow up incomplete, this combination of new technologies ap pears to offer the potential for the expansion of the indications for percutaneous coronary intervention, obviating the need for coronary surgery in selected high risk situations. of a 116 p core optical fiber contained in a soft polyurethane catheter (Trimedyne Inc.). The distal 2 cm of thefiber, between the catheter and the 1.7-mm diameter tip, was enclosed in ajloppy spiral metal coil that further enhanced the probe flexibility.
A guidewire channel passed up the length of the catheter and through the center of the tip allowing it to be advanced over a 0.01 I-inch guidewire. An Optilase argon laser (Trimedyne Inc.) set at 10 watts (>80% coupling efficiency) was used to heat the tip. Patients in whom balloon angioplasty had been or was likely to be unsatisfactory were considered for percutaneous laser thermal probeassisted angioplasty. Our standard angioplasty regimen includes heparin 10,000 U during the procedure; in addition aspirin 300 mg 3 times/day and dipyridamole 100 mg 3 times/ day were commenced 2 days before the procedure. A temporary pacing electrode was placed in the right ven-
